Nov. 19 (UPI) — Federal well being officers introduced the rollout Thursday of a multi-state pilot program for a transportable, molecular take a look at that gives fast outcomes for COVID-19.
The Well being and Human Providers Division stated the brand new “point-of-care” diagnostic know-how, developed by Cue Well being, has been accepted to be used on trial foundation in 5 states — Florida, Louisiana, New Jersey, Texas and Alaska.
The nasal swab take a look at generates ends in about 20 minutes, Cue Well being says. Beforehand, molecular COVID-19 exams needed to be despatched to a laboratory for interpretation, which may take days.
The brand new diagnostic take a look at is identical one which was utilized by the Nationwide Basketball Affiliation in Orlando, Fla., over the summer time to curb the virus’ unfold in its “bubble” setting.
“The Cue Well being testing system will undoubtedly be a worthwhile addition to our testing ecosystem,” HHS Assistant Secretary for Well being Brett Giroir stated in an announcement.
“Having a extremely particular and delicate POC molecular take a look at may dramatically enhance an infection management at nursing properties and different institutional settings particularly.”
The division stated it shipped 27,000 of the take a look at kits earlier this month, together with 9,000 to Alaska and 4,000 every to the opposite 4 states.
The division has already accepted varied fast antigen exams for COVID-19 that can provide same-day outcomes — typically inside minutes. Antigen exams, nonetheless, are thought of rather less correct and sometimes have to be verified by a molecular take a look at. Within the interim, an individual ready for the second take a look at must isolate.
“With Cue’s COVID-19 Take a look at, verifying the antigen take a look at outcomes may be accomplished on the spot in lots of circumstances,” Giroir added. “The pilot program will assist us decide how effectively the Cue take a look at can be tailored in establishments and communities.”